FATE · Categories · Form 4

FATE - SEC Form 4 insider transactions

Fate Therapeutics Inc. (FATE) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for FATE

• 18d
  Officer Tahl Cindy sold $48,084 worth of shares (25,590 units at $1.88), decreasing direct ownership by 4% to 628,155 units (SEC Form 4) (withholding obligation)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 18d
  President and CEO Valamehr Bahram sold $54,482 worth of shares (28,946 units at $1.88), decreasing direct ownership by 4% to 635,762 units (SEC Form 4) to satisfy withholding tax

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 32d
  Officer Tahl Cindy exercised 166,664 shares at a strike of $1.25, increasing direct ownership by 34% to 653,745 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 33d
  Director Epstein Robert S exercised 25,000 shares at a strike of $1.69, increasing direct ownership by 221% to 36,331 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 33d
  Director Rastetter William H exercised 25,000 shares at a strike of $1.69, increasing direct ownership by 221% to 36,331 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 46d
  Amendment: SEC Form 4 filed by Director Redmile Group, Llc

  4/A - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 47d
  SEC Form 4 filed by Redmile Group, Llc

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 143d
  Officer Tahl Cindy was granted 100,000 shares, increasing direct ownership by 26% to 487,081 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 143d
  Chief Financial Officer Adawi Kamal was granted 25,000 shares, increasing direct ownership by 33% to 100,000 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 143d
  President and CEO Valamehr Bahram was granted 335,000 shares, increasing direct ownership by 102% to 664,708 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 147d
  Officer Tahl Cindy sold $11,275 worth of shares (10,589 units at $1.06), decreasing direct ownership by 3% to 387,081 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 147d
  President and CEO Valamehr Bahram sold $5,557 worth of shares (5,190 units at $1.07), decreasing direct ownership by 2% to 329,708 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 230d
  Chief Financial Officer Adawi Kamal was granted 75,000 shares (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 307d
  Officer Tahl Cindy sold $9,573 worth of shares (9,037 units at $1.06), decreasing direct ownership by 2% to 397,670 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 307d
  President and CEO Valamehr Bahram sold $15,396 worth of shares (14,466 units at $1.06), decreasing direct ownership by 4% to 334,898 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 374d
  SEC Form 4 filed by Director Lee Michael Stewart

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 374d
  SEC Form 4 filed by Director Redmile Group, Llc

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 374d
  SEC Form 4 filed by Director Xu Yuan

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 374d
  SEC Form 4 filed by Director Mozaffarian Neelufar

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 374d
  SEC Form 4 filed by Director Rastetter William H

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 374d
  SEC Form 4 filed by Director Mendlein John

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 374d
  SEC Form 4 filed by Director Jooss Karin

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 374d
  SEC Form 4 filed by Director Epstein Robert S

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 374d
  SEC Form 4 filed by Director Abernethy Matt

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 374d
  SEC Form 4 filed by Director Agarwal Shefali

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 508d
  SEC Form 4 filed by President and CEO Valamehr Bahram

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 508d
  Officer Tahl Cindy was granted 70,000 shares, increasing direct ownership by 21% to 406,707 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 508d
  Officer Bressi Jerome Charles was granted 65,000 shares, increasing direct ownership by 24% to 335,203 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 511d
  Officer Bressi Jerome Charles sold $9,269 worth of shares (5,980 units at $1.55), decreasing direct ownership by 2% to 270,203 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 511d
  Officer Tahl Cindy sold $8,764 worth of shares (5,654 units at $1.55), decreasing direct ownership by 2% to 336,707 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 511d
  President and CEO Valamehr Bahram sold $13,406 worth of shares (8,705 units at $1.54), decreasing direct ownership by 2% to 349,364 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 539d
  Director Redmile Group, Llc converted options into 30,110 shares (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 670d
  Director Xu Yuan sold $2,678 worth of shares (633 units at $4.23), decreasing direct ownership by 7% to 8,669 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 677d
  Chief R&D Officer Valamehr Bahram was granted 200,000 shares, increasing direct ownership by 127% to 358,069 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 677d
  SEC Form 4 filed by Director Mozaffarian Neelufar

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 677d
  General Counsel and Secretary Tahl Cindy was granted 200,000 shares, increasing direct ownership by 140% to 342,361 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 727d
  SEC Form 4 filed by Director Lee Michael Stewart

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 727d
  SEC Form 4 filed by Director Redmile Group, Llc

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 727d
  SEC Form 4 filed by Director Rastetter William H

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 727d
  SEC Form 4 filed by Director Jooss Karin

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 727d
  SEC Form 4 filed by Director Coughlin Timothy

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 727d
  SEC Form 4 filed by Director Agarwal Shefali

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 727d
  SEC Form 4 filed by Director Xu Yuan

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 727d
  SEC Form 4 filed by Director Epstein Robert S

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 727d
  SEC Form 4 filed by Director Mendlein John

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 805d
  SEC Form 4 filed by Redmile Group, Llc

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 857d
  SEC Form 4 filed by Wolchko J Scott

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 857d
  SEC Form 4 filed by Tahl Cindy

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 857d
  SEC Form 4 filed by Dulac Edward J Iii

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 857d
  SEC Form 4 filed by Valamehr Bahram

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 860d
  Dulac Edward J Iii sold $9,245 worth of shares (1,849 units at $5.00), decreasing direct ownership by 2% to 103,926 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 880d
  Tahl Cindy sold $47,519 worth of shares (10,874 units at $4.37), decreasing direct ownership by 7% to 142,361 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 880d
  Valamehr Bahram sold $49,367 worth of shares (11,271 units at $4.38), decreasing direct ownership by 7% to 158,069 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 880d
  Wolchko J Scott sold $62,889 worth of shares (14,391 units at $4.37), decreasing direct ownership by 4% to 371,248 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 880d
  Dulac Edward J Iii sold $30,712 worth of shares (7,028 units at $4.37), decreasing direct ownership by 6% to 105,775 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 887d
  Dulac Edward J Iii sold $18,966 worth of shares (5,182 units at $3.66), decreasing direct ownership by 4% to 112,803 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 902d
  Dulac Edward J Iii sold $5,548 worth of shares (1,585 units at $3.50), decreasing direct ownership by 1% to 117,985 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 938d
  Tahl Cindy sold $58,471 worth of shares (24,363 units at $2.40), decreasing direct ownership by 14% to 153,235 units (SEC Form 4)

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 1022d
  SEC Form 4: Dulac Edward J Iii sold $13,210 worth of shares (4,718 units at $2.80), decreasing direct ownership by 4% to 119,570 units

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)
• 1036d
  SEC Form 4: Xu Yuan sold $2,345 worth of shares (632 units at $3.71), decreasing direct ownership by 6% to 9,302 units

  4 - FATE THERAPEUTICS INC (0001434316) (Issuer)

Other FATE categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends